Mellor, Andrew L <br/><br/>
Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  Nov 2005 
 - 5601-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-1767 
<br/><br/><label>Standard No.: </label>10.4049/jimmunol.175.9.5601  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--pharmacology<br/>Animals<br/>Antigens, CD19--analysis<br/>CD11c Antigen--analysis<br/>Dendritic Cells--drug effects<br/>Indoleamine-Pyrrole 2,3,-Dioxygenase--biosynthesis<br/>Interferon-alpha--physiology<br/>Mice<br/>Oligodeoxyribonucleotides--pharmacology<br/>STAT1 Transcription Factor--metabolism<br/>Signal Transduction--physiology<br/>Spleen--immunology<br/>T-Lymphocytes, Regulatory--physiology